ASNRT — Arab Society of Nephrology and Renal Transplantation

النسخة العربية من هذه الصفحة

Daratumumab for antibody-mediated rejection: Is it time to target the real culprit?

Insights into novel therapies for managing antibody-mediated rejection can enhance transplant outcomes.

Category

Transplant

Source

Am J Transplant

Read the full abstract on PubMed

More from ASNRT News

Browse the latest news, society announcements, KDIGO guideline updates, and AJNT issue releases on the ASNRT newsroom.

All news · ASNRT home